BARICICH, Alessio
 Distribuzione geografica
Continente #
EU - Europa 4.471
NA - Nord America 3.167
AS - Asia 2.605
SA - Sud America 453
AF - Africa 135
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.847
Nazione #
US - Stati Uniti d'America 3.041
RU - Federazione Russa 1.102
IE - Irlanda 826
SG - Singapore 765
IT - Italia 633
CN - Cina 556
FR - Francia 452
HK - Hong Kong 406
DE - Germania 400
SE - Svezia 380
VN - Vietnam 350
BR - Brasile 329
UA - Ucraina 241
IN - India 127
GB - Regno Unito 117
FI - Finlandia 114
CA - Canada 88
KR - Corea 64
AR - Argentina 49
ID - Indonesia 47
IR - Iran 47
JP - Giappone 43
BJ - Benin 41
NL - Olanda 33
BD - Bangladesh 32
ZA - Sudafrica 31
MX - Messico 29
TR - Turchia 29
ES - Italia 28
PL - Polonia 25
BE - Belgio 24
CZ - Repubblica Ceca 24
IQ - Iraq 24
EG - Egitto 23
EC - Ecuador 21
PK - Pakistan 19
AT - Austria 17
AU - Australia 14
MY - Malesia 13
PE - Perù 13
CL - Cile 11
KE - Kenya 11
LT - Lituania 10
PH - Filippine 10
PY - Paraguay 10
TW - Taiwan 10
UZ - Uzbekistan 9
JO - Giordania 8
SA - Arabia Saudita 8
TH - Thailandia 8
VE - Venezuela 8
NG - Nigeria 7
RS - Serbia 7
CH - Svizzera 6
DZ - Algeria 6
TN - Tunisia 5
BG - Bulgaria 4
CO - Colombia 4
MA - Marocco 4
MD - Moldavia 4
MO - Macao, regione amministrativa speciale della Cina 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
GR - Grecia 3
KZ - Kazakistan 3
LV - Lettonia 3
MK - Macedonia 3
OM - Oman 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
UY - Uruguay 3
BO - Bolivia 2
BY - Bielorussia 2
EU - Europa 2
GY - Guiana 2
KH - Cambogia 2
LB - Libano 2
LI - Liechtenstein 2
TT - Trinidad e Tobago 2
AL - Albania 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GM - Gambi 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
MT - Malta 1
MV - Maldive 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
Totale 10.843
Città #
Dublin 819
Jacksonville 392
Hong Kong 389
Singapore 329
San Jose 279
Ashburn 234
Beijing 174
Dearborn 168
Chandler 161
Wilmington 117
Lauterbourg 113
Moscow 112
Los Angeles 107
Ho Chi Minh City 105
Princeton 99
Lawrence 98
Ann Arbor 87
Hanoi 71
Piemonte 70
San Mateo 67
Buffalo 64
New York 56
Seoul 52
Novara 47
Munich 44
Turin 43
Helsinki 42
São Paulo 42
Cotonou 41
Milan 39
Orem 39
Chennai 34
Dallas 33
Montreal 33
Andover 31
Boardman 31
Rome 31
Dong Ket 30
Frankfurt am Main 30
Bremen 27
Nuremberg 27
Vercelli 26
Jakarta 25
Johannesburg 25
Brussels 24
Poplar 23
Redondo Beach 23
Falkenstein 22
Brno 21
Council Bluffs 21
Tokyo 21
Stockholm 20
Warsaw 20
London 19
Amsterdam 18
Toronto 18
Guangzhou 17
Haiphong 17
Houston 16
Santa Clara 16
Denver 15
Nanjing 15
Tianjin 14
Atlanta 13
Phoenix 13
Vienna 13
Zanjan 13
Ankara 12
Da Nang 12
Mumbai 12
Woodbridge 12
Manchester 11
Mexico City 11
Turku 11
Chicago 10
Fairfield 10
Hangzhou 10
Kunming 10
Monza 10
Nairobi 10
Al Maḩallah al Kubrá 9
Boston 9
Hefei 9
Seattle 9
Shanghai 9
Alessandria 8
Amman 8
Baghdad 8
Belo Horizonte 8
Cairo 8
Melbourne 8
Norwalk 8
Ottawa 8
Quito 8
Tehran 8
The Dalles 8
Bangkok 7
Bari 7
Curitiba 7
Guayaquil 7
Totale 5.597
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 371
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 248
Clinical and instrumental evaluation of Botulinum Toxin type A safety profile in post stroke spasticity rehabilitation treatment 226
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 190
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 174
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 155
Buccal hemineglect: is it useful to evaluate the differences between the two halves of the oral cavity for the multidisciplinary rehabilitative management of right brain stroke survivors? A cross-sectional study 150
Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients 149
A Rare Cause of Back Pain During Pregnancy and Lactation: Management and Treatment 143
Sarcopenic dysphagia: a narrative review 142
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 141
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 137
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. 135
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 131
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up 127
RIEDUCAZIONE DEL CAMMINO NEL MORBO DI PARKINSON: TRATTAMENTO ROBOTIZZATO VERSUS TRAINING SU TREADMILL. STUDIO RANDOMIZZATO CONTROLLATO 122
Effects of Denosumab on Bone Turnover Markers compared to Zoledronic Acid in severe osteoporotic women: a randomized head to head study 118
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature 118
Can scoliosis lead to spinal cord ischaemia? Early diagnosis and rehabilitation: A paradigmatic case report and literature review 115
Spinal Cord Injury as a Model of Bone-Muscle Interactions: Therapeutic Implications From in vitro and in vivo Studies 114
ONCE YEARLY ZOLEDRONIC ACID AFTER 18 MONTHS OF PARATHYROID HORMONE (1-84) FOR SEVERE OSTEOPOROSIS 113
Heart Rate Variability modifications induced by high doses of incobotulinumtoxinA and onabotulinumtoxinA in hemiplegic chronic stroke patients: A single blind randomized controlled, crossover pilot study 111
A new mutation in the CAVIN1/PTRF gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature 109
Accurate gait analysis in post-stroke patients using a single inertial measurement unit 109
MULTIMODAL ANALGESIA AND REHABILITATION PROTOCOL IN TOTAL KNEE REPLACEMENT: A PILOT STUDY 107
Long-lasting consequences of Coronavirus disease 19 pneumonia: a systematic review 106
Abobotulinumtoxina and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis 105
Chronic stroke: an oxymoron or a challenge for rehabilitation? 102
Peripheral facial nerve palsy: how effective is rehabilitation? 99
Post-COVID-19 sequelae are associated with sustained SARS-CoV-2-specific CD4+ immune responses 98
Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients 98
Administration of type a botulinum toxin after total hip replacement 98
Clinical characteristics that impact onabotulinumtoxinA treatment adherence in patients with spasticity from ASPIRE 96
The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study 95
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke 94
Long-term effects of intra-articular oxygen-ozone therapy versus hyaluronic acid in older people affected by knee osteoarthritis: A randomized single-blind extension study 94
A single-blinded,randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot 93
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 92
Recovery from vegetative state of patients with a severe brain injury: a 4-year real-practice prospective cohort study 92
Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study 92
Balance Rehabilitation through Robot-Assisted Gait Training in Post-Stroke Patients: A Systematic Review and Meta-Analysis 90
The value of adding mirror therapy for upper limb motor recovery of subacute stroke patients: a randomized controlled trial. 90
Evaluation of the safety profile of intra-articular treatment with Oxygen-Ozone therapy in knee arthrosis: controlled randomized study 90
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN POST-STROKE PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 90
La valutazione dell’outcome nel percorso riabilitativo della protesi di ginocchio 89
Once Yearly Zoledronic Acid After 18 months of Parathyroid Hormone (1-84) for Severe Osteoporosis 87
Adherence to onabotulinumtoxina treatment in multiple sclerosis patients with spasticity from the aspire study 87
What is the impact of robotic rehabilitation on balance and gait outcomes in people with multiple sclerosis? A systematic review of randomized control trials 87
Robotic gait training is not superior to conventional treadmill training in Parkinson's Disease: A single-blind randomized controlled trial 86
Sonographic and clinical effects of botulinum toxin Type A combined with extracorporeal shock wave therapy on spastic muscles of children with cerebral palsy 86
Risk factors and outcome in falls 86
Optimization of transdisciplinary management of elderly with femur proximal extremity fracture: A patient-tailored plan from orthopaedics to rehabilitation 86
Efficacy of a Hip Flexion Assist Orthosis in Adults With Hemiparesis After Stroke. 84
Efficacy and safety of a hip flexion assist orthosis in adult hemiplegic stroke patients 84
Heart rate variability (hrv) modifications in adult hemiplegic patients after botulinum toxin type a (nt-201) injection. 84
Low back pain related to a sacral insufficiency fracture: Role of paravertebral oxygen-ozone therapy in a paradigmatic case of nociplastic pain 84
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach 84
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from the ASPIRE Study 84
People with Spinal Cord Injury in Italy 82
From paper to informatics: the Post Soft Care-App, an easy-to-use and fast tool to help therapists identify unmet needs in stroke patients 82
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 81
Confronto randomizzato, controllato in doppio cieco tra casting e taping nel trattamento riabilitativo dopo tossina botulinica A 80
Robotic gait training is not superior to conventional treadmill training in parkinson disease: a single-blind randomized controlled trial. 80
Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study 80
Power Doppler Ultrasound Findings before and after Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Pilot Study on Pain Reduction and Neovascularization Effect 79
Differentiation among bio- and augmented- feedback in technologically assisted rehabilitation 79
Triceps surae muscle characteristics in spastic hemiparetic stroke survivors treated with botulinum toxin type a: Clinical implications from ultrasonographic evaluation 79
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 78
Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study 77
Effects of Robot-Assisted Training for the Unaffected Arm in Patients with Hemiparetic Cerebral Palsy: A Proof-of-Concept Pilot Study 77
ABOBOTULINUMTOXINA AND REHABILITATION VERSUS REHABILITATION ALONE IN POSTSTROKE SPASTICITY: AN ITALIAN COST-UTILITY ANALYSIS 77
Rectus femoris characteristics in post stroke spasticity: Clinical implications from ultrasonographic evaluation 77
Effects of robot-assisted gait training on postural instability in parkinson's disease: A systematic review 77
Tolerability, Safety and Efficacy of a Specific Rehabilitation Treatment Protocol for Axillary Web Syndrome: An Observational Retrospective Study 77
Once yearly Zoledronic Acid in Osteoporotic PD Patients compared to agematched osteoporotic post menopausal women 76
High-Intensity Exercise Training Impact on Cardiorespiratory Fitness, Gait Ability, and Balance in Stroke Survivors: A Systematic Review and Meta-Analysis 75
Botulinum Toxin for Pain Relief in Cancer Patients: A Systematic Review of Randomized Controlled Trials 75
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke 75
Indicatori di qualità per la continuità delle cure in Medicina Riabilitativa 74
Multidimensional Effectiveness of Botulinum Toxin in Neuropathic Pain: A Systematic Review of Randomized Clinical Trials 74
Falls, fractures and bone density in Parkinson’s disease–a cross-sectional study 73
Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study 73
Development of new biomarkers in the prevention of lymphedema related to breast cancer: a multidisciplinary challenge 71
Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: An observational study 70
Post Soft Care: Italian implementation of a post-stroke checklist software for primary care and identification of unmet needs in community-dwelling patients 70
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from ASPIRE 70
Is spasticity always the same? An observational study comparing the features of spastic equinus foot in patients with chronic stroke and multiple sclerosis 69
Post-stroke spasticity: follow-up and functional implications of chronic long-term treatment with botulinum toxin 68
Does altering inclination alter effectiveness of treadmill training for gait impairment after stroke? A randomized controlled trial. 68
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study 67
Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment 67
High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis 66
Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals? 65
Valutazione comparativa di tre diversi protocolli riabilitativi post-inoculo di tossina botulinica A sull’ipertono spastico dell’arto inferiore 65
Management of spasticity with onabotulinumtoxinA: Practical guidance based on the Italian real-life post-stroke spasticity survey 65
Management of stroke patients submitted to botulinum toxin type a therapy: A Delphi survey of an Italian expert panel of specialist injectors 65
Ultrasound-guided injection of botulinum toxin type a for piriformis muscle syndrome: A case report and review of the literature 65
Transcranial Direct Current Stimulation Combined with Botulinum Neurotoxin Type A Injections for Treatment of Upper Limb Intention Tremor in Multiple Sclerosis: A Case Report 65
Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects 64
Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis 62
Totale 9.826
Categoria #
all - tutte 58.010
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.010


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021193 0 0 0 0 0 0 0 0 0 46 98 49
2021/2022905 41 13 148 67 57 54 52 52 62 61 119 179
2022/20231.644 129 79 74 35 91 147 52 87 810 18 68 54
2023/2024833 61 48 49 27 105 29 150 62 19 61 75 147
2024/20251.538 49 24 68 32 55 163 181 151 359 122 67 267
2025/20264.423 209 186 351 686 444 355 649 858 335 350 0 0
Totale 11.062